Literature DB >> 20428311

Management of treatment-resistant panic disorder.

Richard L Holt1, R Bruce Lydiard.   

Abstract

Panic disorder (PD) is a severe, chronic disorder characterized by one or more unexpected panic attacks followed by worry about additional attacks and/or the implications of the attacks. If attacks are sufficiently severe or frequent, they can promote marked, sometimes debilitating behavioral changes. Many panic disorder sufferers appear to be incompletely responsive to treatment and are subject to relapse after remission. In this article, we highlight the current understanding of the pathophysiology of PD using a "fear circuit" model. Using this model as a reference point, we review the evidence base supporting existing and emerging treatments and suggest strategies for optimizing initial treatment response. Finally, a differential diagnostic approach for clinical evaluation of unsatisfactory response to treatment in PD is presented.

Entities:  

Keywords:  cognitive behavioral; comorbidity; drug treatment; panic disorder; treatment resistance

Year:  2007        PMID: 20428311      PMCID: PMC2860526     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  93 in total

Review 1.  Neuroanatomical hypothesis of panic disorder, revised.

Authors:  J M Gorman; J M Kent; G M Sullivan; J D Coplan
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

2.  Early coadministration of clonazepam with sertraline for panic disorder.

Authors:  A W Goddard; T Brouette; A Almai; P Jetty; S W Woods; D Charney
Journal:  Arch Gen Psychiatry       Date:  2001-07

3.  The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.

Authors:  Laurel K Leslie; Thomas B Newman; P Joan Chesney; James M Perrin
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

4.  Multicenter collaborative panic disorder severity scale.

Authors:  M K Shear; T A Brown; D H Barlow; R Money; D E Sholomskas; S W Woods; J M Gorman; L A Papp
Journal:  Am J Psychiatry       Date:  1997-11       Impact factor: 18.112

5.  The structure of genetic and environmental risk factors for anxiety disorders in men and women.

Authors:  John M Hettema; Carol A Prescott; John M Myers; Michael C Neale; Kenneth S Kendler
Journal:  Arch Gen Psychiatry       Date:  2005-02

6.  The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Robert Jin; Ayelet Meron Ruscio; Katherine Shear; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2006-04

7.  The diagnosis and drug treatment of anxiety disorders.

Authors:  D V Sheehan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1983       Impact factor: 5.067

Review 8.  Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder.

Authors:  M G Gelder
Journal:  J Clin Psychopharmacol       Date:  1998-12       Impact factor: 3.153

9.  Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.

Authors:  I M Lesser; R B Lydiard; E Antal; R T Rubin; J C Ballenger; R DuPont
Journal:  Am J Psychiatry       Date:  1992-11       Impact factor: 18.112

10.  Relationship of childhood sexual and physical abuse to anxiety disorders.

Authors:  C Mancini; M Van Ameringen; H MacMillan
Journal:  J Nerv Ment Dis       Date:  1995-05       Impact factor: 2.254

View more
  8 in total

1.  Sulpiride and refractory panic disorder.

Authors:  Emerson A Nunes; Rafael C Freire; Moema Dos Reis; Adriana Cardoso de Oliveira E Silva; Sérgio Machado; José A S Crippa; Serdar M Dursun; Glen B Baker; Jaime E C Hallak; Antonio E Nardi
Journal:  Psychopharmacology (Berl)       Date:  2012-08-05       Impact factor: 4.530

Review 2.  Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults.

Authors:  Hui Li; Jijun Wang; Chunbo Li; Zeping Xiao
Journal:  Cochrane Database Syst Rev       Date:  2014-09-17

3.  Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review.

Authors:  Wicher A Bokma; Guido A A M Wetzer; Jurriaan B Gehrels; Brenda W J H Penninx; Neeltje M Batelaan; Anton L J M van Balkom
Journal:  Depress Anxiety       Date:  2019-06-23       Impact factor: 6.505

Review 4.  Panic disorder in general medical practice- A narrative review.

Authors:  Narayana Manjunatha; Dushad Ram
Journal:  J Family Med Prim Care       Date:  2022-03-10

5.  Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report.

Authors:  Dushad Ram; Shwetha Patil; Basavana Gowdappa; Iyshwarya Rajalakshmi
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-12-31       Impact factor: 2.582

6.  Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis.

Authors:  Marie Ociskova; Jan Prasko; Kristyna Vrbova; Petra Kasalova; Michaela Holubova; Ales Grambal; Klara Machu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-01-26       Impact factor: 2.570

7.  Effects of Aerobic Exercise on Anxiety Symptoms and Cortical Activity in Patients with Panic Disorder: A Pilot Study.

Authors:  Eduardo Lattari; Henning Budde; Flávia Paes; Geraldo Albuquerque Maranhão Neto; José Carlos Appolinario; Antônio Egídio Nardi; Eric Murillo-Rodriguez; Sérgio Machado
Journal:  Clin Pract Epidemiol Ment Health       Date:  2018-02-21

8.  An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder.

Authors:  Anish Shah; Joanne Northcutt
Journal:  Ann Gen Psychiatry       Date:  2018-05-11       Impact factor: 3.455

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.